These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35996405)

  • 61. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression.
    Groth C; Hu X; Weber R; Fleming V; Altevogt P; Utikal J; Umansky V
    Br J Cancer; 2019 Jan; 120(1):16-25. PubMed ID: 30413826
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
    Song S; Wang Y; Wang J; Lian W; Liu S; Zhang Z; Liu F; Wei L
    Eur J Cancer; 2012 Sep; 48(14):2252-9. PubMed ID: 22230748
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Randomized controlled trial of juzen-taiho-to in children with recurrent acute otitis media.
    Ito M; Maruyama Y; Kitamura K; Kobayashi T; Takahashi H; Yamanaka N; Harabuchi Y; Origasa H; Yoshizaki T
    Auris Nasus Larynx; 2017 Aug; 44(4):390-397. PubMed ID: 27810126
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reduction of splenic immunosuppressive cells and enhancement of anti-tumor immunity by synergy of fish oil and selenium yeast.
    Wang H; Chan YL; Li TL; Bauer BA; Hsia S; Wang CH; Huang JS; Wang HM; Yeh KY; Huang TH; Wu GJ; Wu CJ
    PLoS One; 2013; 8(1):e52912. PubMed ID: 23349693
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The influence of CD25+ cells on the generation of immunity to tumour cell lines in mice.
    Jones E; Golgher D; Simon AK; Dahm-Vicker M; Screaton G; Elliott T; Gallimore A
    Novartis Found Symp; 2004; 256():149-52; discussion 152-7, 259-69. PubMed ID: 15027488
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differences in the phenotypes of cells mediating anti-tumour immunity at various stages of tumour progression in mice.
    Dent LA; Spencer LK; Attridge S; Finlay-Jones JJ
    Immunol Cell Biol; 1989 Dec; 67 ( Pt 6)():403-12. PubMed ID: 2696727
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity.
    Seo N; Hayakawa S; Takigawa M; Tokura Y
    Immunology; 2001 Aug; 103(4):449-57. PubMed ID: 11529935
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.
    Kobori H; Hashiguchi M; Piao J; Kato M; Ritprajak P; Azuma M
    Immunology; 2010 Jul; 130(3):363-73. PubMed ID: 20141543
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice.
    Shu C; Sun P; Xie H; Huang W; Qi J; Ma Y
    Int J Nanomedicine; 2020; 15():1983-1996. PubMed ID: 32308382
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Juzen-Taiho-to, an herbal medicine, promotes the differentiation of transplanted bone marrow cells into microglia in the mouse brain injected with fibrillar amyloid β.
    Liu H; Wang J; Tabira T
    Tohoku J Exp Med; 2014 Jun; 233(2):113-22. PubMed ID: 24869594
    [TBL] [Abstract][Full Text] [Related]  

  • 71. TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression.
    Nakamura S; Yaguchi T; Kawamura N; Kobayashi A; Sakurai T; Higuchi H; Takaishi H; Hibi T; Kawakami Y
    J Immunother; 2014; 37(2):63-72. PubMed ID: 24509168
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Kampo Medicine Treatment for Advanced Pancreatic Cancer: A Case Series.
    Shimizu M; Takayama S; Kikuchi A; Arita R; Ono R; Ishizawa K; Ishii T
    Front Nutr; 2021; 8():702812. PubMed ID: 34458306
    [No Abstract]   [Full Text] [Related]  

  • 73. Reciprocal relationship of T regulatory cells and monocytic myeloid-derived suppressor cells in LP-BM5 murine retrovirus-induced immunodeficiency.
    O'Connor MA; Vella JL; Green WR
    J Gen Virol; 2016 Feb; 97(2):509-522. PubMed ID: 26253145
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-seiryu-to"--effects on aged mice, against subtypes of a viruses and B virus, and therapeutic effect.
    Nagai T; Urata M; Yamada H
    Immunopharmacol Immunotoxicol; 1996 May; 18(2):193-208. PubMed ID: 8771367
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
    Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
    Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Janus face of CD4+CD25+ regulatory T cells in cancer and autoimmunity.
    Danese S; Rutella S
    Curr Med Chem; 2007; 14(6):649-66. PubMed ID: 17346153
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Prognostic value of tumor infiltration immune cells in pancreatic cancer].
    Zhao KL; Liu J; Jiang WN; Hao JH
    Zhonghua Wai Ke Za Zhi; 2018 Jun; 56(6):464-470. PubMed ID: 29886672
    [No Abstract]   [Full Text] [Related]  

  • 78. 5-Aza-2'-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy.
    Wachowska M; Gabrysiak M; Muchowicz A; Bednarek W; Barankiewicz J; Rygiel T; Boon L; Mroz P; Hamblin MR; Golab J
    Eur J Cancer; 2014 May; 50(7):1370-81. PubMed ID: 24559534
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Contrasting effects of cyclophosphamide on anti-CTL-associated protein 4 blockade therapy in two mouse tumor models.
    Iida Y; Harashima N; Motoshima T; Komohara Y; Eto M; Harada M
    Cancer Sci; 2017 Oct; 108(10):1974-1984. PubMed ID: 28787548
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Exosomes from CIITA-transfected CT26 cells enhance anti- tumor effects.
    Fan W; Tian XD; Huang E; Zhang JJ
    Asian Pac J Cancer Prev; 2013; 14(2):987-91. PubMed ID: 23621273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.